Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

17.14
Delayed Data
As of Mar 24
 -0.01 / -0.06%
Today’s Change
9.06
Today|||52-Week Range
18.53
+12.10%
Year-to-Date
Synergy Pharmaceuticals: Approval, Now What?
Mar 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close17.15
Today’s open17.21
Day’s range16.97 - 17.42
Volume1,051,573
Average volume (3 months)1,354,160
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+44.00%
Earnings growth (this year)-19.60%
Earnings growth (next 5 years)+39.00%
Revenue growth (last year)+83.18%
P/E ratioNM
Price/Sales8.09
Price/Book37.82

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-2.60-3.99%
HCMHutchison China Medi...+0.30+1.60%
HZNPHorizon Pharma PLC-0.19-1.30%
CBPOChina Biologic Produ...+0.03+0.03%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$274.0M
Annual profit (last year)-$81.7M
Net profit margin-29.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
Chief Financial Officer &
SVP-Corporate Strategy
Thomas Graney
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs